Literature DB >> 31645412

Reply to Chu et al., "Adoption of the New CLSI Fluoroquinolone Breakpoints for Enterobacteriaceae".

Tam T Van1,2, Emi Minejima3, Chiao An Chiu3, Susan M Butler-Wu4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31645412      PMCID： PMC6813016          DOI： 10.1128/JCM.01268-19

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  7 in total

Review 1.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Authors:  Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

2.  Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis.

Authors:  F J Vasallo; P Martín-Rabadán; L Alcalá; J M García-Lechuz; M Rodríguez-Créixems; E Bouza
Journal:  Clin Infect Dis       Date:  1998-02       Impact factor: 9.079

Review 3.  Don't Get Wound Up: Revised Fluoroquinolone Breakpoints for Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  Tam T Van; Emi Minejima; Chiao An Chiu; Susan M Butler-Wu
Journal:  J Clin Microbiol       Date:  2019-06-25       Impact factor: 5.948

4.  Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test.

Authors:  A Hakanen; P Kotilainen; J Jalava; A Siitonen; P Huovinen
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

5.  Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

Authors:  George G Zhanel; Tamiko L Hisanaga; Nancy M Laing; Melanie R DeCorby; Kim A Nichol; Barb Weshnoweski; Jack Johnson; Ayman Noreddin; Don E Low; James A Karlowsky; Daryl J Hoban
Journal:  Int J Antimicrob Agents       Date:  2006-05-18       Impact factor: 5.283

6.  Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae.

Authors:  John A Crump; Timothy J Barrett; Jennifer T Nelson; Frederick J Angulo
Journal:  Clin Infect Dis       Date:  2003-06-20       Impact factor: 9.079

7.  Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy.

Authors:  Kurt G Naber; Giancarlo Schito; Henry Botto; Juan Palou; Teresita Mazzei
Journal:  Eur Urol       Date:  2008-05-21       Impact factor: 20.096
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.